Psychiatry
Suicidal Ideation
13
Pipeline Programs↗
16
Active Trials↗
8
Companies Involved↗
Suicidal Ideation is an emerging landscape with 13 programs across 8 companies. The most active players are Sichuan Purity Pharmaceutical Technology Co., Ltd., Avalo Therapeutics, Inc., COMPASS Pathways. 5 therapies are approved with 4 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 23
Phase 34
Analysis
Trial Status
43
clinical trials
Completed11 · 26%
Unknown status9 · 21%
Recruiting9 · 21%
Withdrawn5 · 12%
Not yet recruiting4 · 9%
Enrolling by invitation3 · 7%
Other2 · 5%
Clinical Trials
Trial Activity
43 trials
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 2/3·NCT05696691·24 enrolled
Study of IV Ketamine for Emergency Department Treatment of Adolescent Suicidal Ideation
Recruiting·—·N/A·NCT06366334·20 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)